228 related articles for article (PubMed ID: 34839279)
1. Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients.
Xuan DTM; Wu CC; Kao TJ; Ta HDK; Anuraga G; Andriani V; Athoillah M; Chiao CC; Wu YF; Lee KH; Wang CY; Chuang JY
Aging (Albany NY); 2021 Nov; 13(22):24882-24913. PubMed ID: 34839279
[TBL] [Abstract][Full Text] [Related]
2. Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer.
Kao TJ; Wu CC; Phan NN; Liu YH; Ta HDK; Anuraga G; Wu YF; Lee KH; Chuang JY; Wang CY
Aging (Albany NY); 2021 Jul; 13(14):17970. PubMed ID: 34329194
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma.
Li Y; Liu X; Zhao F; Zhao Z; Li X; Wang J; Huang B; Chen A
CNS Neurosci Ther; 2024 Feb; 30(2):e14366. PubMed ID: 37485655
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Significance of Proteasome 26S Subunit, Non-ATPase (PSMD) Genes for Bladder Urothelial Carcinoma Patients.
Salah Fararjeh A; Al-Khader A; Al-Saleem M; Abu Qauod R
Cancer Inform; 2021; 20():11769351211067692. PubMed ID: 34992336
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Immune Infiltration Value of Proteasome Assembly Chaperone (PSMG) Family Genes in Lung Adenocarcinoma.
Xuan DTM; Yeh IJ; Su CY; Liu HL; Ta HDK; Anuraga G; Chiao CC; Wang CY; Yen MC
Int J Med Sci; 2023; 20(1):87-101. PubMed ID: 36619227
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer.
Chiao CC; Liu YH; Phan NN; An Ton NT; Ta HDK; Anuraga G; Minh Xuan DT; Fitriani F; Putri Hermanto EM; Athoillah M; Andriani V; Ajiningrum PS; Wu YF; Lee KH; Chuang JY; Wang CY; Kao TJ
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943457
[TBL] [Abstract][Full Text] [Related]
7. PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.
Li X; Li X; Hu Y; Liu O; Wang Y; Li S; Yang Q; Lin B
BMC Cancer; 2023 Jun; 23(1):573. PubMed ID: 37349676
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value and Molecular Mechanisms of Proteasome 26S Subunit, Non-ATPase Family Genes for Pancreatic Ductal Adenocarcinoma Patients after Pancreaticoduodenectomy.
Zhou C; Li H; Han X; Pang H; Wu M; Tang Y; Luo X
J Invest Surg; 2022 Feb; 35(2):330-346. PubMed ID: 33525943
[No Abstract] [Full Text] [Related]
9. Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.
Wu CC; Ekanem TI; Phan NN; Loan DTT; Hou SY; Lee KH; Wang CY
Int J Med Sci; 2020; 17(18):3112-3124. PubMed ID: 33173433
[TBL] [Abstract][Full Text] [Related]
10. 26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
Rubio AJ; Bencomo-Alvarez AE; Young JE; Velazquez VV; Lara JJ; Gonzalez MA; Eiring AM
Cells; 2021 Sep; 10(9):. PubMed ID: 34572038
[TBL] [Abstract][Full Text] [Related]
11. Proteasome 26S subunit PSMD1 regulates breast cancer cell growth through p53 protein degradation.
Okumura T; Ikeda K; Ujihira T; Okamoto K; Horie-Inoue K; Takeda S; Inoue S
J Biochem; 2018 Jan; 163(1):19-29. PubMed ID: 28992264
[TBL] [Abstract][Full Text] [Related]
12. PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation.
Li Y; Huang J; Zeng B; Yang D; Sun J; Yin X; Lu M; Qiu Z; Peng W; Xiang T; Li H; Ren G
Cancer Lett; 2018 Aug; 430():109-122. PubMed ID: 29777785
[TBL] [Abstract][Full Text] [Related]
13. The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.
Li Y; Huang J; Sun J; Xiang S; Yang D; Ying X; Lu M; Li H; Ren G
Oncotarget; 2017 Jan; 8(3):4501-4519. PubMed ID: 27966459
[TBL] [Abstract][Full Text] [Related]
14. Analysis of LAGEs Family Gene Signature and Prognostic Relevance in Breast Cancer.
Khoa Ta HD; Tang WC; Phan NN; Anuraga G; Hou SY; Chiao CC; Liu YH; Wu YF; Lee KH; Wang CY
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33921749
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma.
Zhao H; Lu G
Front Genet; 2022; 13():905581. PubMed ID: 35754829
[No Abstract] [Full Text] [Related]
16. PSMD12 promotes breast cancer growth via inhibiting the expression of pro-apoptotic genes.
Du X; Shen X; Dai L; Bi F; Zhang H; Lu C
Biochem Biophys Res Commun; 2020 May; 526(2):368-374. PubMed ID: 32222279
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
[TBL] [Abstract][Full Text] [Related]
19. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
[TBL] [Abstract][Full Text] [Related]
20. Signaling network analysis of ubiquitin-mediated proteins suggests correlations between the 26S proteasome and tumor progression.
Fu C; Li J; Wang E
Mol Biosyst; 2009 Dec; 5(12):1809-16. PubMed ID: 19593471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
